The mechanism of action of methotrexate. II. Augmentation by vincristine of inhibition of deoxyribonucleic aic synthesis by methotrexate in Ehrlich ascites tumor cells
- PMID: 4859543
The mechanism of action of methotrexate. II. Augmentation by vincristine of inhibition of deoxyribonucleic aic synthesis by methotrexate in Ehrlich ascites tumor cells
Similar articles
-
The mechanism of action of methotrexate. I. Interaction with a low-affinity intracellular site required for maximum inhibition of deoxyribonucleic acid synthesis in L-cell mouse fibroblasts.Mol Pharmacol. 1974 Mar;10(2):257-74. Mol Pharmacol. 1974. PMID: 4859542 No abstract available.
-
A basis for fluoropyrimidine-induced antagonism to methotrexate in Ehrlich ascites tumor cells in vitro.Cancer Res. 1978 Jan;38(1):219-22. Cancer Res. 1978. PMID: 618577
-
Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.J Clin Invest. 1973 Aug;52(8):1804-11. doi: 10.1172/JCI107362. J Clin Invest. 1973. PMID: 4719662 Free PMC article.
-
Host zinc nutrition and Ehrlich ascites tumor growth.Nutr Rev. 1980 Mar;38(3):131-3. doi: 10.1111/j.1753-4887.1980.tb05869.x. Nutr Rev. 1980. PMID: 6990318 Review. No abstract available.
-
Molecular mechanism of methotrexate action in inflammation.Inflammation. 1992 Oct;16(5):411-23. doi: 10.1007/BF00918968. Inflammation. 1992. PMID: 1428120 Review. No abstract available.
Cited by
-
Methotrexate and the need for continued research.Yale J Biol Med. 1975 May;48(2):97-103. Yale J Biol Med. 1975. PMID: 1154813 Free PMC article. No abstract available.
-
[Multidrug chemotherapy of osteogenic sarcoma (author's transl)].Blut. 1979 Oct;39(4):293-300. doi: 10.1007/BF01013224. Blut. 1979. PMID: 291443 German.
-
Effect of interaction between methotrexate and dihydrofolate reductase on DNA synthesis in L1210 cells in vitro.Br J Cancer. 1978 Mar;37(3):403-10. doi: 10.1038/bjc.1978.60. Br J Cancer. 1978. PMID: 638018 Free PMC article.
-
High-dose methotrexate with citrovorum factor rescue in non-small-cell lung cancer.Cancer Chemother Pharmacol. 1978;1(4):255-7. doi: 10.1007/BF00257159. Cancer Chemother Pharmacol. 1978. PMID: 373922 Clinical Trial.
-
Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma.Head Neck. 2011 Dec;33(12):1804-8. doi: 10.1002/hed.21478. Epub 2010 Jul 22. Head Neck. 2011. PMID: 20652976 Free PMC article.